Fish oil supplements (4 g) for 3 months improved lipid and glucose levels, liver function and the circulating biomarkers FGF21 and CK18 fragment, and performed anti-inflammation functions in patients with NAFLD associated with hyperlipidemia. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.